Skip to content

FocalPoint Advises Apex Innovative Sciences on its Sale to CenExel

CenExel is the Most Prolific Wholly Owned Neuroscience Research Site Network in the World

SALT LAKE CITY — CenExel Clinical Research, Inc. (“CenExel”) completed the acquisition of Apex Innovative Sciences (“Apex”), parent company of Collaborative Neuroscience Research (“CNS”) and Hassman Research Institute (“HRI”), which will be renamed as “CenExel CNS” and “CenExel HRI”, respectively. Bison Capital, a growth-oriented private equity group, completed a minority investment in Apex in 2019. FocalPoint Partners (“FocalPoint”) served as exclusive financial advisor to Apex on its initial capital raise and on the company’s sale to CenExel.